Sandbox tachy: Difference between revisions

Jump to navigation Jump to search
(Created page with "<div style="width: 80%;"> ==FIRE: Focused Initial Rapid Evaluation== A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate...")
 
mNo edit summary
Line 6: Line 6:
A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.
A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.
{{familytree/start |summary=Sample 1}}
{{familytree/start |summary=Sample 1}}
{{familytree | | | | | | | | | | | | | A01 | | | | A01=[[Tachycardia]]}}
{{familytree | | | | | | | | | | | | | A01 | | | | A01=[[Tachycardia]] }}
{{familytree | | | | | | | | | | | | | |!| | | | | | }}
{{familytree | | | | | | | | | | | | | |!| | | | | | }}
{{familytree | | | | | | | | | |,|-|-|-|^|-|-|-|.| | }}
{{familytree | | | | | | | | | |,|-|-|-|^|-|-|-|.| | }}
{{familytree | | | | | | | | | B01 | | | | | | B02 | }}
{{familytree | | | | | | | | | B01 | | | | | | B02 | B01=Pulse | B02=No Pulse }}
{{familytree | | | | | | | | | |!| | | | | | | |!| | }}
{{familytree | | | | | | | | | |!| | | | | | | |!| | }}
{{familytree | | | | | | | | | C01 | | | | | | C02 | }}
{{familytree | | | | | | | | | X01 | | | | | | X02 | X01=<b>Evaluate and treat instability:</b> |X02=Pulseless tachycardia}}
{{familytree |boxstyle=border-top: 0px | | | | | | | | | C01 | | | | | | C02 | C01=<div style="text-align: left;">
❑&nbsp;&nbsp;12-lead ECG, don't delay therapy <BR>
❑&nbsp;&nbsp;IV/IO access <BR>
❑&nbsp;&nbsp;Ventilation <BR>
❑&nbsp;&nbsp;Supplementary oxygen if hypoxemic <BR>
❑&nbsp;&nbsp;Check heart rate and blood pressure <BR>
❑&nbsp;&nbsp;Check signs of end-organ [[hypoperfusion|<span style="color: #000000;">hypoperfusion</span>]] <BR>
: ❑&nbsp;&nbsp;[[Altered mental status|<span style="color: #000000;">Altered mental status</span>]] <BR>
: ❑&nbsp;&nbsp;[[Cold extremities|<span style="color: #000000;">Cold extremities</span>]] <BR>
: ❑&nbsp;&nbsp;[[Cyanosis|<span style="color: #000000;">Cyanosis</span>]] <BR>
: ❑&nbsp;&nbsp;[[Oliguria|<span style="color: #000000;">Oliguria</span>]] ([[urine output|<span style="color: #000000;">urine output</span>]] &lt;0.5 mL/kg/h) <BR>
: ❑&nbsp;&nbsp;Sustained [[hypotension|<span style="color: #000000;">hypotension</span>]] (≥30 min) <BR>
:: ❑&nbsp;&nbsp;[[SBP|<span style="color: #000000;">SBP</span>]] &lt;90 mm Hg ''or'' <BR>
:: ❑&nbsp;&nbsp;[[MAP|<span style="color: #000000;">MAP</span>]] ↓ &gt;30 mm Hg below baseline <BR>
: ❑&nbsp;&nbsp;Ischemic chest discomfort <BR>
: ❑&nbsp;&nbsp;Acute heart failure</div>| C02=[[Cardiac arrest resident survival guide#Cardiac Arrest Care: Algorithm 2|Proceed to<BR>ACLS Cardiac Arrest Algorithm]]}}
{{familytree | | | | | | | | | |!| | | | | | | | | | }}
{{familytree | | | | | | | | | |!| | | | | | | | | | }}
{{familytree | | | | | |,|-|-|-|^|-|-|-|.| | | | | | }}
{{familytree | | | | | |,|-|-|-|^|-|-|-|.| | | | | | }}
{{familytree | | | | | D01 | | | | | | D02 | | | | | }}
{{familytree | | | | | D01 | | | | | | D02 | | | | | D01=Hemodynamic stable|D02=Hemodynamic unstable}}
{{familytree | | | | | |!| | | | | | | |!| | | | | | }}
{{familytree | | | | | |!| | | | | | | |!| | | | | | }}
{{familytree | | | | | E01 | | | | | | E02 | | | | | }}
{{familytree | | | | | E01 | | | | | | E02 | | | | | E01=Check duration of QRS|E02=<u>Synchronized cardioversion:</u> <br> Consider sedation <br> If regular narrow complex, consider adenosine'''| F02='''<u>Doses/details of synchronized cardioversion:</u> <br> Narrow regular: 50-100 Joule <br> Narrow irregular: 120-200 Joule biphasic or 200 Joule monophasic <br> wide regular 100 Joule <br> Wide irregular: defibrillation dose (Not synchronized) <br><u>Adenosine IV dose:</u> <br> First dose: 6mg rapid IV push; follow with NS flush <br> Second dose: 12mg if required}}
{{familytree | |,|-|-|-|^|-|-|-|.| | | |!| | | | | | }}
{{familytree | |,|-|-|-|^|-|-|-|.| | | |!| | | | | | }}
{{familytree | F01 | | | | | | F02 | | F03 | | | | | }}
{{familytree | F01 | | | | | | F02 | | F03 | | | | | F01=[[Wide complex tachycardia|Wide complex tachycardia (≥120 ms)]]|F02=[[Narrow complex tachycardia|Narrow complex tachycardia (<120 ms)]] | F03 =<div style="text-align: left;">
❑&nbsp;&nbsp;<u>Doses/details of synchronized cardioversion:</u> <br>
: ❑&nbsp;&nbsp;Narrow regular: 50-100 Joule <br>
: ❑&nbsp;&nbsp;Narrow irregular: 120-200 Joule biphasic or 200 Joule monophasic <br>
: ❑&nbsp;&nbsp;Wide regular 100 Joule <br>
: ❑&nbsp;&nbsp;Wide irregular: defibrillation dose (Not synchronized) <br>
❑&nbsp;&nbsp;<u>Adenosine IV dose:</u> <br>
: ❑&nbsp;&nbsp;First dose: 6mg rapid IV push; follow with NS flush <br>
: ❑&nbsp;&nbsp;Second dose: 12mg if required</div>}}
{{familytree | |!| | | | | | | |!| | | |!| | | | | | }}
{{familytree | |!| | | | | | | |!| | | |!| | | | | | }}
{{familytree | G01 | | | | | | G02 | | G03 | | | | | }}
{{familytree | G01 | | | | | | G02 | | G03 | | | | | G01=Consider expert consultation <br> Consider antiarrhythmic infusion <br> Consider adenosine only if monomorphic and regular|G02=Vagal maneuvers <br> Beta-Blockers or calcium channel blocker <br> Consider expert consultation <br> Adenosine if regular|G03=[[Hemodynamic instability|Proceed to Hemodynamic instability resident survival guide]]}}
{{familytree | |!| | | | | | | |!| | | | | | | | | | }}
{{familytree | |!| | | | | | | |!| | | | | | | | | | }}
{{familytree | H01 | | | | | | H02 | | | | | | | | | }}
{{familytree | H01 | | | | | | H02 | | | | | | | | | H01=<div style="text-align: left;">
❑&nbsp;&nbsp;<u>Antiarrhythmic infusion for stable wide-QRS tachycardia:</u> <br>
: ❑&nbsp;&nbsp;Procainamide IV Dose: <br>
:: ❑&nbsp;&nbsp;20-50mg/min until arrhythmia suppressed, hypotension ensues, QRS duration increases 50%, or maximum dose 17mg/kg given. <br>
:: ❑&nbsp;&nbsp;Maintenance infusion: 1-4 mg/min. <br>
:: ❑&nbsp;&nbsp;Avoid if prolonged QT or CHF. <br>
: ❑&nbsp;&nbsp;Amiodarone IV Dose: <br>
:: ❑&nbsp;&nbsp;First dose: 150mg over 10 minutes. Repeat as needed if VT recurs. <br>
:: ❑&nbsp;&nbsp;Follow by maintenance infusion by 1mg/min for first 6 hours. <br>
: ❑&nbsp;&nbsp;Sotalol IV Dose: <br>
:: ❑&nbsp;&nbsp;100mg (1.5mg/kg) over 5 minutes. <br>
:: ❑&nbsp;&nbsp;Avoid if prolonged QT.</div>|H02=[[Narrow complex tachycardia resident survival guide|Proceed to Narrow complex tachycardia resident survival guide]]}}
{{familytree | |!| | | | | | | | | | | | | | | | | | }}
{{familytree | |!| | | | | | | | | | | | | | | | | | }}
{{familytree | I01 | | | | | | | | | | | | | | | | | }}
{{familytree | I01 | | | | | | | | | | | | | | | | | I01=[[Wide complex tachycardia resident survival guide|Proceed to Wide complex tachycardia resident survival guide]]}}
{{familytree/end}}
{{familytree/end}}
<!--
{{familytree | | | | | | | | |!| | | | | | | | }}
{{familytree | | | | | | | | B01 |-|-|-|-|-|-|-|-|-|-|-|-|-|-|-|-|-|-|-|-|-| B02 | B01=Pulse| B02=No Pulse}}
{{familytree | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | |!| }}
{{familytree | | | | | | | | |!| | | | | | | | | | | | | | | | | | | | | | | C01| C01=[[Cardiac arrest resident survival guide#Cardiac Arrest Care: Algorithm 2|Proceed to ACLS Cardiac Arrest Algorithm]]}}
{{familytree | | | | | | | | D01 | | | | | | | | | | | | | | | | | | | | | | | | | D01='''<u>Evaluate and treat instability:</u> <br> 12-lead ECG, don't delay therapy <br> IV/IO access <br> Ventilation <br> Oxygenation (if hypoxemic provide supplementary oxygen) <br> Heart rate <br> Blood pressure <br> Acute altered mental status <br> Signs of shock <br> Ischemic chest discomfort <br> Acute heart failure'''}}
{{familytree | | | | | | | | |!| | | | | | | | }}
{{familytree | | | | |,|-|-|-|^|-|-|-|-|.| | | }}
{{familytree | | | E01 | | | | | | | | E02 | | | E01=Hemodynamic stable| E02=Hemodynamic unstable}}
{{familytree | | | |!| | | | | | | | | |!| }}
{{familytree | | | |!| | | | | | | | | F01 |-|-|-|-|-|-|-|F02| F01='''<u>Synchronized cardioversion:</u> <br> Consider sedation <br> If regular narrow complex, consider adenosine'''| F02='''<u>Doses/details of synchronized cardioversion:</u> <br> Narrow regular: 50-100 Joule <br> Narrow irregular: 120-200 Joule biphasic or 200 Joule monophasic <br> wide regular 100 Joule <br> Wide irregular: defibrillation dose (Not synchronized) <br><u>Adenosine IV dose:</u> <br> First dose: 6mg rapid IV push; follow with NS flush <br> Second dose: 12mg if required'''}}
{{familytree | | | G01 | | | | | | | G01=Check duration of QRS }}
{{familytree | |,|-|^|.| | | | | | | | | | }}
{{familytree | H01 | | H02 | | | | | | | | | H01=[[Wide complex tachycardia|QRS wider than 0.12 seconds]]| H02=[[Narrow complex tachycardia|QRS narrower than 0.12]]}}
{{familytree | |!| | | |!| | | | | | | | | | | }}
{{familytree | I01 | | I02 | | | | | | | | I01=Consider expert consultation <br> Consider antiarrhythmic infusion <br> Consider adenosine only if monomorphic and regular| I02=Vagal maneuvers <br> Beta-Blockers or calcium channel blocker <br> Consider expert consultation <br> Adenosine if regular}}
{{familytree | |!| | | | | | | | | | | | | | | }}
{{familytree | J01 | | | | | | | | | | | J01='''<u>Antiarrhythmic infusion for stable wide-QRS tachycardia:</u> <br> Procainamide IV Dose: <br> 20-50mg/min until arrhythmia suppressed, hypotension ensues, QRS duration increases 50%, or maximum dose 17mg/kg given. Maintenance infusion: 1-4 mg/min. Avoid if prolonged QT or CHF. <br> Amiodaron IV Dose: <br> First dose: 150mg over 10 minutes. Repeat as needed if VT recurs. Follow by maintenance infusion by 1mg/min for first 6 hours. <br> Sotalol IV Dose: <br> 100mg (1.5mg/kg) over 5 minutes. Avoid if prolonged QT.'''}}
''Algorithm based on the 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care.''<ref name="pmid20956224">{{cite journal| author=Neumar RW, Otto CW, Link MS, Kronick SL, Shuster M, Callaway CW et al.| title=Part 8: adult advanced cardiovascular life support: 2010 American Heart Association Guidelines for Cardiopulmonary Resuscitation and Emergency Cardiovascular Care. | journal=Circulation | year= 2010 | volume= 122 | issue= 18 Suppl 3 | pages= S729-67 | pmid=20956224 | doi=10.1161/CIRCULATIONAHA.110.970988 | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=20956224  }} </ref>
-->




</div>
</div>

Revision as of 20:32, 2 March 2015


FIRE: Focused Initial Rapid Evaluation

A Focused Initial Rapid Evaluation (FIRE) should be performed to identify patients in need of immediate intervention.

 
 
 
 
 
 
 
 
 
 
 
 
Tachycardia
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Pulse
 
 
 
 
 
No Pulse
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Evaluate and treat instability:
 
 
 
 
 
Pulseless tachycardia
 
 
 
 
 
 
 
 

❑  12-lead ECG, don't delay therapy
❑  IV/IO access
❑  Ventilation
❑  Supplementary oxygen if hypoxemic
❑  Check heart rate and blood pressure
❑  Check signs of end-organ hypoperfusion

❑  Altered mental status
❑  Cold extremities
❑  Cyanosis
❑  Oliguria (urine output <0.5 mL/kg/h)
❑  Sustained hypotension (≥30 min)
❑  SBP <90 mm Hg or
❑  MAP ↓ >30 mm Hg below baseline
❑  Ischemic chest discomfort
❑  Acute heart failure
 
 
 
 
 
Proceed to
ACLS Cardiac Arrest Algorithm
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Hemodynamic stable
 
 
 
 
 
Hemodynamic unstable
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Check duration of QRS
 
 
 
 
 
Synchronized cardioversion:
Consider sedation
If regular narrow complex, consider adenosine
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Wide complex tachycardia (≥120 ms)
 
 
 
 
 
Narrow complex tachycardia (<120 ms)
 

❑  Doses/details of synchronized cardioversion:

❑  Narrow regular: 50-100 Joule
❑  Narrow irregular: 120-200 Joule biphasic or 200 Joule monophasic
❑  Wide regular 100 Joule
❑  Wide irregular: defibrillation dose (Not synchronized)

❑  Adenosine IV dose:

❑  First dose: 6mg rapid IV push; follow with NS flush
❑  Second dose: 12mg if required
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Consider expert consultation
Consider antiarrhythmic infusion
Consider adenosine only if monomorphic and regular
 
 
 
 
 
Vagal maneuvers
Beta-Blockers or calcium channel blocker
Consider expert consultation
Adenosine if regular
 
Proceed to Hemodynamic instability resident survival guide
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 

❑  Antiarrhythmic infusion for stable wide-QRS tachycardia:

❑  Procainamide IV Dose:
❑  20-50mg/min until arrhythmia suppressed, hypotension ensues, QRS duration increases 50%, or maximum dose 17mg/kg given.
❑  Maintenance infusion: 1-4 mg/min.
❑  Avoid if prolonged QT or CHF.
❑  Amiodarone IV Dose:
❑  First dose: 150mg over 10 minutes. Repeat as needed if VT recurs.
❑  Follow by maintenance infusion by 1mg/min for first 6 hours.
❑  Sotalol IV Dose:
❑  100mg (1.5mg/kg) over 5 minutes.
❑  Avoid if prolonged QT.
 
 
 
 
 
Proceed to Narrow complex tachycardia resident survival guide
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Proceed to Wide complex tachycardia resident survival guide